Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 28, 2006; 12(44): 7097-7103
Published online Nov 28, 2006. doi: 10.3748/wjg.v12.i44.7097
Published online Nov 28, 2006. doi: 10.3748/wjg.v12.i44.7097
Figure 1 Meta-analysis comparing odds of having a NOD2 variant (SNPs 8,12 and/or 13) among Ileal versus Colonic CD patients in 10 studies.
Pooled estimate = 2.50 (95% CI 1.97-3.25), P < 0.0001), test of heterogeneity among studies, P = 0.49.
Figure 2 Meta-analysis comparing odds of having a NOD2 variant among Ileocolonic versus Colonic CD patients in 10 studies.
Pooled estimate = 2.13 (95% CI 1.7-2.7), P < 0.0001, test of heterogeneity among studies, P = 0.927.
Figure 3 Meta-analysis comparing odds of having a NOD2 variant among Stricturing versus Inflammatory CD patients in nine studies.
Pooled estimate = 2.06 (95% CI 1.42-2.98), P < 0.0001, test of heterogeneity among studies, P = 0.02.
Figure 4 Meta-analysis comparing odds of having a NOD2 variant among Penetrating versus Inflammatory CD patients in nine studies.
Pooled estimate = 1.47 (95% CI 1.19-1.82), P < 0.0001, test of heterogeneity among studies, P = 0.15.
- Citation: Radford-Smith G, Pandeya N. Associations between NOD2/CARD15 genotype and phenotype in Crohn’s disease-Are we there yet? World J Gastroenterol 2006; 12(44): 7097-7103
- URL: https://www.wjgnet.com/1007-9327/full/v12/i44/7097.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i44.7097